1253689 - Glycomimetics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - GLYC (1253689)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
20 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1+1+1-5+0
S2-0+0-4-26

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-06-11
GLYCHahn Brian M.CFOS - Sale+OE$18.04-19,3450-100%-$348,984
D
2018-06-11
GLYCHahn Brian M.CFOM - OptEx$1.12+5,2600-100%+$5,891
D
2018-05-23
GLYCMagnani John L.SVP of Research, CSOM - OptEx$0.33+1,491105,638+1%+$492
D
2018-05-10
GLYCSandell Scott D10%X - OptEx$0.33514,4529,089,041-5%$169,769
D
2018-05-10
GLYCSandell Scott D10%S - Sale+OE$17.81-9,5399,089,0410%-$169,890
D
2018-05-10
GLYCBarris Peter J10%S - Sale+OE$17.81-9,5399,089,0410%-$169,890
D
2018-05-10
GLYCBarris Peter J10%X - OptEx$0.33514,4529,089,041-5%$169,769
D
2018-05-10
GLYCBarrett M JamesDir, 10%S - Sale+OE$17.81-9,5399,089,0410%-$169,890
D
2018-05-10
GLYCBarrett M JamesDir, 10%X - OptEx$0.33514,4529,089,041-5%$169,769
D
2018-05-10
GLYCNew Enterprise Associates 10 L P10%S - Sale+OE$17.81-9,5394,995,6640%-$169,890
D
2018-05-10
GLYCNew Enterprise Associates 10 L P10%X - OptEx$0.33514,4524,995,664-9%$169,769
2017-12-08
GLYCThackray Helen M.SVP Clinical Development, CMOS - Sale$15.01-2,000148,615-1%-$30,020
2017-09-18
GLYCThackray Helen M.SVP Clinical Development, CMOS - Sale$13.00-2,000150,615-1%-$26,000
2017-06-15
GLYCJunius Daniel MDirA - Grant$11.27+3,0008,000+60%+$33,810
2017-05-25
GLYCThackray Helen M.SVP Clinical Development, CMOS - Sale$15.57-2,000152,615-1%-$31,140
2017-05-19
GLYCThackray Helen M.SVP Clinical Development, CMOS - Sale$12.14-2,000154,615-1%-$24,280
D
2017-05-10
GLYCMagnani John L.SVP of Research, CSOM - OptEx$1.12+8,928104,147+9%+$9,999+23
2016-12-20
GLYCJunius Daniel MDirP - Purchase$6.01+5,0005,000New+$30,050+1+1-5
2016-10-03
GLYCThackray Helen M.VP Clinical Development, CMOS - Sale$7.00-4,000156,615-2%-$28,001-1-5-8-24
2016-07-20
GLYCThackray Helen M.VP Clinical Development, CMOS - Sale$8.00-2,000160,615-1%-$16,0000+5-1-28

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top